Products
Return to Previous Page
COVID-19 Products
The biomedical community is working urgently to develop novel reagents specific for COVID-19 (2019-nCov, SARS-CoV-2). Please find below our latest list of reagents for Australian and New Zealand researchers. If you can't find what you are looking for, please take a look at our original coronavirus product page or contact us
6 Item(s)
per page
Product Name |
Product Number |
Supplier |
Size |
|
| Anti-SARS-CoV-2 Nucleocapsid / COVID-19, Humanized antibody | MBS355887 | MyBioSource | 0.1mg, 1mg, 5x1mg | |
| Anti-SARS-CoV-2 Nucleocapsid / COVID-19, Humanized antibody | MBS355888 | MyBioSource | 0.1mg, 1mg, 5x1mg | |
| Anti- SARS-CoV-2 Nucleocapsid / COVID-19, Humanized antibody | MBS355897 | MyBioSource | 0.1mg, 1mg, 5x1mg | |
| Anti-SARS-CoV-2 S1 / COVID-19, Humanized antibody (Capture Ab) | MBS355889 | MyBioSource | 0.1mg, 1mg, 5x1mg | |
| Anti-SARS-CoV-2 Spike RBD IgG, Humanized antibody (Positive Control) | MBS355893 | MyBioSource | 1ml, 5x1ml | |
| Anti-SARS-CoV-2 Spike RBD IgG/IgM, Humanized antibody (Positive Control) | MBS355896 | MyBioSource | 1ml, 5x1ml |
6 Item(s)
per page